Prostate Cancer

Initial Treatment Options for Prostate Cancer by Stage and Risk Group

There are many ways to treat prostate cancer, and the best approach can vary from person to person. Typical options depend on how far the cancer has spread and how likely it is to grow or spread. Other factors, such as your age, overall health, and preferences, can also help determine which treatments might be best for you.

What affects treatment options for prostate cancer?

The stage of your cancer is one of the most important factors in choosing the best way to treat it. Prostate cancer is staged based on the extent of the cancer (using T, N, and M categories) and the PSA level and Gleason score (Grade Group) when it is first diagnosed.

For prostate cancers that haven’t spread (stages I to III), doctors also use risk groups and sometimes special lab tests to help guide treatment options.

Risk groups are based on how far the prostate tumor has grown, PSA level, grade, and prostate biopsy results. They range from very low-risk to very high-risk.

Cancers in the lower-risk groups have a smaller chance of growing and spreading compared to those in higher-risk groups.

Other factors, such as your age, overall health, life expectancy, and personal preferences, are also important when looking at treatment options. This is especially true for early-stage cancers, where you might have several options.

You might want to ask which factors your doctor is considering when discussing your treatment options. There is also some variability in what different doctors consider to be “standard” options, so some doctors might recommend options different from those listed here.

Taking part in a clinical trial of newer treatments is also an option for many men with prostate cancer.

Treatment options by stage and risk group

These prostate cancers are very unlikely to grow and spread, even if they aren’t treated. For men whose cancers are in this group, active surveillance is typically recommended.

This is because these tumors are unlikely to cause any harm, while treatments such as radiation and surgery can have side effects that can affect a man’s quality of life. If the cancer starts to show signs of growing at some point, treatments such as surgery or radiation can then be considered.

For men who have medical problems that might shorten their lifespan, observation, which is a less intense form of monitoring, might be an option as well.

For men who aren’t comfortable with just monitoring the cancer and choose to start treatment right away, radiation therapy (external beam or brachytherapy) or surgery (radical prostatectomy) may be options.

Another option for some men who prefer to treat the cancer might be some type of focal therapy, such as cryotherapy or high-intensity focused ultrasound (HIFU). However, most expert groups don’t recommend these as a first treatment, unless surgery and radiation aren’t good options. This is mainly because there isn’t enough long-term data yet to show whether these treatments are as effective as surgery or radiation.

If surgery is done and it finds concerning features in the cancer, your doctor might recommend external radiation therapy to the prostate bed (the area where the prostate was before it was removed), possibly along with hormone therapy.

Most men whose prostate cancers are in the low-risk group will be offered active surveillance (or observation, for men who have other serious health issues that might affect their lifespan), because very few of these cancers will spread to distant parts of the body. If the cancer starts to show signs of growing at some point, treatments such as surgery or radiation can then be considered.

Other options, depending on a man’s preferences, might include radiation therapy (external beam or brachytherapy) or surgery (radical prostatectomy).

Another option for some men who prefer to treat the cancer might be some type of focal therapy, such as cryotherapy or high-intensity focused ultrasound (HIFU). However, most expert groups don’t recommend these as a first treatment, unless surgery and radiation aren’t good options. This is mainly because there isn’t enough long-term data yet to show whether these treatments are as effective as surgery or radiation.

If surgery is done and it finds concerning features in the cancer, your doctor might recommend external radiation therapy to the prostate bed (the area where the prostate was before it was removed), possibly along with hormone therapy.

These cancers are slightly more likely to grow and spread. Initial treatment options might include:

  • Active surveillance
  • Surgery (radical prostatectomy, possibly with the removal of nearby lymph nodes)
  • Radiation therapy (external beam or brachytherapy)

Another option for some men who prefer to treat the cancer might be some type of focal therapy, such as cryotherapy or high-intensity focused ultrasound (HIFU). However, most expert groups don’t recommend these as a first treatment, unless surgery and radiation aren’t good options. This is mainly because there isn’t enough long-term data yet to show whether these treatments are as effective as surgery or radiation.

If surgery is done and it finds concerning features in the cancer, your doctor might recommend external radiation therapy to the prostate bed (the area where the prostate was before it was removed), possibly along with hormone therapy. If cancer is found in the lymph nodes, hormone therapy might be recommended, possibly along with external radiation.

Men who have other serious medical problems that might affect their lifespan may choose a less aggressive first treatment such as radiation alone, or less intensive monitoring (observation).

Initial treatment options for cancers in this risk group might include:

If surgery is done and it finds concerning features in the cancer, your doctor might recommend external radiation therapy to the prostate bed (the area where the prostate was before it was removed), possibly along with hormone therapy. If cancer is found in the lymph nodes, hormone therapy might be recommended, possibly along with external radiation.

Men who have other serious medical problems that might affect their lifespan may choose a less aggressive first treatment such as radiation therapy (possibly with hormone therapy), or less intensive monitoring (observation).

For men with cancers that are at high or very high risk of growing and spreading, treatment options might include:

  • Radiation therapy (external beam radiation, either alone or with brachytherapy) along with hormone therapy (typically for 1 to 3 years). For cancers in the very-high-risk group, the newer hormone drug abiraterone is often included as well.
  • Surgery (radical prostatectomy, along with the removal of nearby lymph nodes)

If surgery is done and it finds concerning features in the cancer, your doctor might recommend external radiation therapy to the prostate bed (the area where the prostate was before it was removed), possibly along with hormone therapy. If cancer is found in the lymph nodes, hormone therapy might be recommended, possibly along with external radiation.

Men who have other serious medical problems that might affect their lifespan may choose a less aggressive first treatment, such as external radiation therapy or hormone therapy, or less intensive monitoring (observation).

Stage IVA (locally advanced) cancers have already spread to nearby lymph nodes (but not to distant parts of the body) when the cancer is first found. For men who don’t have other serious medical problems that might affect their lifespan or who are having symptoms from the cancer, options include:

  • External beam radiation treatment with hormone therapy (which often includes the newer hormone drug abiraterone)
  • Hormone therapy (which might include abiraterone)
  • Surgery (radical prostatectomy, along with the removal of nearby lymph nodes), only for those who are most likely to benefit from it

If surgery is done and it finds concerning features in the cancer, your doctor might recommend external radiation therapy to the prostate bed (the area where the prostate was before it was removed), possibly along with hormone therapy. If cancer is found in the lymph nodes, hormone therapy might be recommended, possibly along with external radiation.

Men who have other serious medical problems that might affect their lifespan and who aren’t having symptoms may choose a less aggressive first treatment such as hormone therapy, or less intensive monitoring (observation).

Stage IVB (metastatic) cancers have spread to distant organs such as the bones when the cancer is found. Most stage IVB cancers can’t be cured, but they are treatable. The goals of treatment are to keep the cancer under control for as long as possible and to improve a man’s quality of life. Initial treatment options may include:

  • Hormone therapy, usually with abiraterone, apalutamide, or enzalutamide
  • Hormone therapy with a newer hormone drug such as abiraterone or darolutamide, plus chemotherapy, usually docetaxel, especially if there's a lot of cancer in the body
  • Hormone therapy plus niraparib, a type of PARP inhibitor drug, for men whose cancer cells have a change in the BRCA2 gene
  • Hormone therapy plus capivasertib (an AKT inhibitor) and abiraterone, for men whose cancer cells have lost the PTEN gene
  • Hormone therapy along with external beam radiation to the tumor in the prostate
  • Surgery (TURP) to relieve symptoms, such as bleeding or trouble urinating
  • Observation, for men who are older or have other serious health issues and don't have major symptoms from the cancer
  • Taking part in a clinical trial of newer treatments

Treatment of stage IV prostate cancer may also include treatments to help prevent or relieve symptoms, such as pain from bone metastases. This can be done with external radiation (including stereotactic body radiation therapy, or SBRT) or with drugs such as denosumab (Xgeva), a bisphosphonate such as zoledronic acid (Zometa), or a radiopharmaceutical such as radium-223 or strontium-89.

The options above are for the initial treatment of different risk groups and stages of prostate cancer. But if the cancer continues to grow and spread or if it comes back, other treatments might be options, such as immunotherapy, targeted drug therapy, chemotherapy, or other forms of hormone therapy.

See Treating Prostate Cancer That Doesn’t Go Away or Comes Back After Treatment.

side by side logos for American Cancer Society and American Society of Clinical Oncology

Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).

Attard G, Kolinsky MP, Rescigno P, et al. Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial. Nat Med. 2025.

Bekelman JE, Rumble RB, Chen RC, et al. Clinically localized prostate cancer: ASCO clinical practice guideline endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology guideline. J Clin Oncol. 2018;36(32):3251-3258.

Chen RC, Rumble RB, Loblaw DA, et al. Active surveillance for the management of localized prostate cancer (Cancer Care Ontario guideline): American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2016;34(18):2182-2190.

National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Prostate Cancer. Version 5.2026. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf on July 14, 2026.

Nelson WG, Antonarakis ES, Carter HB, et al. Chapter 81: Prostate Cancer. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.

Zelefsky MJ, Morris MJ, and Eastham JA. Chapter 70: Cancer of the Prostate. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2019.

Last Revised: September 11, 2026

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.